Edition:
United States

Haemonetics Corp (HAE.N)

HAE.N on New York Stock Exchange

93.04USD
22 Jun 2018
Change (% chg)

$-0.49 (-0.52%)
Prev Close
$93.53
Open
$93.63
Day's High
$94.62
Day's Low
$92.95
Volume
620,496
Avg. Vol
199,751
52-wk High
$96.84
52-wk Low
$38.51

Latest Key Developments (Source: Significant Developments)

Haemonetics Corp Qtrly Revenue $234.0 Million
Tuesday, 6 Feb 2018 06:36am EST 

Feb 6 (Reuters) - Haemonetics Corp ::QTRLY REVENUE OF $234.0 MILLION WAS UP 2.7 PCT‍​.QTRLY ADJUSTED EARNINGS PER SHARE $0.62; QTRLY LOSS PER SHARE $0.12.BOARD OF DIRECTORS AUTHORIZES $260 MILLION SHARE REPURCHASE PROGRAM‍​.INCURRED $31.3 MILLION OF RESTRUCTURING AND TURNAROUND COSTS IN QUARTER.SEES FISCAL 2018 GAAP EARNINGS PER SHARE $.80 - $.85.SEES FISCAL 2018 ADJUSTED EARNINGS PER SHARE $1.80 - $1.90.SEES FISCAL 2018 FREE CASH FLOW, BEFORE RESTRUCTURING & TURNAROUND OF ABOUT $125 MILLION.SEES FISCAL 2018 CAPITAL EXPENDITURES $40 - 50 MILLION.HAEMONETICS- COMPLEXITY REDUCTION INITIATIVE EXPECTED TO DELIVER $80 MILLION IN ANNUAL RUN RATE SAVINGS; SAVINGS ARE EXPECTED TO BE MINIMAL IN FISCAL 2018.Q3 EARNINGS PER SHARE VIEW $0.44, REVENUE VIEW $227.6 MILLION -- THOMSON REUTERS I/B/E/S.EXPECTS TO INCUR AGGREGATE RESTRUCTURING CHARGES OF $50-$60 MILLION TO COMPLETE COMPLEXITY REDUCTION INITIATIVE.FY2018 EARNINGS PER SHARE VIEW $1.70 -- THOMSON REUTERS I/B/E/S.  Full Article

Haemonetics says ‍on Nov 1, board approved complexity reduction initiative program
Tuesday, 7 Nov 2017 06:40am EST 

Nov 7 (Reuters) - Haemonetics Corp ::Haemonetics - ‍on Nov 1, board approved complexity reduction initiative program, which includes a reduction of headcount and operating costs.Haemonetics Corp- ‍expect savings from program of about $80 million on an annualized basis once program is completed​.Haemonetics says expects to incur between $50 million and $60 million to streamline organizational structure - SEC filing.  Full Article

Haemonetics Corp reports Q1 earnings per share $0.38
Monday, 7 Aug 2017 06:28am EDT 

Aug 7 (Reuters) - Haemonetics Corp :Qtrly earnings per share $0.38; Qtrly adjusted earnings per share $0.33.Q1 earnings per share view $0.31 -- Thomson Reuters I/B/E/S.Qtrly net revenues about $211 million versus about $210 million.Q1 revenue view $212.1 million -- Thomson Reuters I/B/E/S.  Full Article

Haemonetics says CEO Christopher Simon's fiscal year 2017 total compensation was $9.03 million
Monday, 12 Jun 2017 04:58pm EDT 

June 12 (Reuters) - Haemonetics Corp : :Says CEO Christopher Simon's fiscal year 2017 total compensation was $9.03 million .Haemonetics Corp says CFO William Burke's fiscal year 2017 total compensation was $2.45 million.  Full Article

Haemonetics Corp reports qtrly loss per share $0.98
Monday, 8 May 2017 06:00am EDT 

May 8 (Reuters) - Haemonetics Corp : :Haemonetics Corp- fourth quarter fiscal 2017 revenue of $228.1 million, down 6pct compared to the fourth quarter of fiscal 2016.Qtrly loss per share $0.98; qtrly adjusted earnings per share $0.39.Q4 earnings per share view $0.38, revenue view $219.4 million -- Thomson Reuters I/B/E/S.Sees fiscal 2018 adjusted earnings per share of $1.55 - $1.65.FY2018 earnings per share view $1.59 -- Thomson Reuters I/B/E/S.Haemonetics Corp- "overall fiscal 2018 revenue is expected to approximate fiscal 2017 revenue".FY2018 revenue view $899.7 million -- Thomson Reuters I/B/E/S.  Full Article

Haemonetics reports Q3 EPS $0.30
Monday, 6 Feb 2017 06:15am EST 

Haemonetics Corp - : Q3 earnings per share $0.30 . Q3 adjusted earnings per share $0.43 . Says updates full year fiscal 2017 guidance . Reported Q3 fiscal 2017 revenue of $227.8 million, down 2 pct . Q3 earnings per share view $0.41, revenue view $220.3 million -- Thomson Reuters I/B/E/S . Sees 2017 gaap EPS in the high end range of $0.70 - $0.80 . Sees 2017 revenue in the high end range of $850mln - $875mln . Sees 2017 adjusted EPS in the high end range of $1.40 - $1.50 .Fy2017 earnings per share view $1.51, revenue view $873.5 million -- Thomson Reuters I/B/E/S.  Full Article

Haemonetics Q2 earnings $0.38/shr
Monday, 7 Nov 2016 06:00am EST 

Haemonetics Corp : Q2 2017 revenue of $220.3 million, flat with the second quarter of fiscal 2016 as reported, and up 1 percent in constant currency . Qtrly earnings per share $0.38 . Q2 earnings per share view $0.35, revenue view $210.7 million -- Thomson Reuters I/B/E/S . Reaffirms full year fiscal 2017 guidance .On track to achieve $40 million annual savings target.  Full Article

Haemonetics Corp Q1 adjusted earnings per share $0.25
Monday, 1 Aug 2016 06:38am EDT 

Haemonetics Corp : Q1 fiscal 2017 revenue of $210.0 million; Q1 earnings per share $0.20; Q1 adjusted earnings per share $0.25 . Q1 earnings per share view $0.28, revenue view $205.4 million -- Thomson Reuters I/B/E/S . Company affirmed its fiscal 2017 guidance .Full-year 2017 earnings per share view $1.45, revenue view $865.6 million -- Thomson Reuters I/B/E/S.  Full Article

Haemonetics appoints Bill Burke CFO
Monday, 1 Aug 2016 06:00am EDT 

Haemonetics Corp : Haemonetics appoints Bill Burke CFO .Burke will join company from Medtronic Inc.  Full Article

BRIEF-Haemonetics Reports Qtrly Earnings Per Share Of $0.22

* SEES FISCAL 2019 TOTAL REVENUE GROWTH 3 PERCENT TO 5 PERCENT